Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
| ▸ | PPARD | Q03181 | 1/20 | 0.46 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.46 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1664269 | 0.98 | GPR84 (0.53) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL21722453 | 0.79 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL28805128 | 0.77 | GPR84 (0.57) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL14715568 | 0.76 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL2384900 | 0.76 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| Carbamic Acid SCHEMBL8429243 | 0.76 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL29961524 | 0.75 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL136612 | 0.74 | SPHK1 (0.62) | GPR84FFAR1MAPTFFAR4SPHK1 | |
| SCHEMBL7756046 | 0.74 | SPHK1 (0.62) | GPR84FFAR1MAPTFFAR4SPHK1 | |
| SCHEMBL3344513 | 0.74 | SPHK1 (0.62) | GPR84FFAR1MAPTFFAR4SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-11269488-A | — | — | None | — | — | JP | disclosed |
| US-8580235-B2 | Hair cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2013-11-12 | — | — | US | disclosed |
| EP-2305207-B1 | HAIR COSMETIC | SHISEIDO CO LTD (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20110110877-A1 | Hair Cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2011-05-12 | — | — | US | disclosed |
| EP-2305207-A1 | HAIR COSMETIC | Shiseido Company, Ltd. (JP) | 2011-04-06 | — | — | EP | disclosed |
| JP-H11269488-A | DETERGENT COMPOSITION | SHISEIDO CO LTD | 1999-10-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110110877-A1 | Hair Cosmetic | PCNA, CYP51A1, CYP17A1 | GPR84 830/4885FFAR1 666/4885MAPT 1651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.